Covid19 renal disease (MGRS)

From Magnesium
Revision as of 23:58, 29 January 2024 by Ossip Groth (talk | contribs) (Created page with "{{tp|p=34352311|t=2021. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19).|pdf=|usr=}}{{34352311}} {{tp|p=34403563|t=2021. Kidney allograft biopsy findings after COVID-19.|pdf=|usr=}}{{34403563}} {{tp|p=36983889|t=2023. Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report.|pdf=|usr=}}{{36983889}}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


34352311 PDF 2021. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19).Template:34352311
34403563 PDF 2021. Kidney allograft biopsy findings after COVID-19.Template:34403563
36983889 PDF 2023. Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report.Template:36983889

Retrieved from "http://mg.moremed.org:80/w/index.php?title=Covid19_renal_disease_(MGRS)&oldid=190"